vs

Side-by-side financial comparison of Digimarc CORP (DMRC) and SurgePays, Inc. (SURG). Click either name above to swap in a different company.

SurgePays, Inc. is the larger business by last-quarter revenue ($16.2M vs $8.9M, roughly 1.8× Digimarc CORP). Digimarc CORP runs the higher net margin — -47.2% vs -85.6%, a 38.4% gap on every dollar of revenue. On growth, SurgePays, Inc. posted the faster year-over-year revenue change (68.7% vs 2.9%). Over the past eight quarters, Digimarc CORP's revenue compounded faster (-5.3% CAGR vs -28.2%).

Digimarc Corporation is a provider of enterprise software and services. The company's software, which includes digital identifiers, is designed to address counterfeiting, product authenticity, recycling accuracy, and supply chain traceability. Digimarc products are created for multiple industries such as apparel, consumer packaged goods, health and beauty, and automotive.

SurgePays, Inc. is a U.S.-headquartered fintech and telecommunications company focused on serving underbanked and low-income communities across the country. It offers prepaid wireless plans, reloadable debit cards, digital banking solutions, and daily consumer products through a nationwide network of independent local retail partners such as convenience stores.

DMRC vs SURG — Head-to-Head

Bigger by revenue
SURG
SURG
1.8× larger
SURG
$16.2M
$8.9M
DMRC
Growing faster (revenue YoY)
SURG
SURG
+65.8% gap
SURG
68.7%
2.9%
DMRC
Higher net margin
DMRC
DMRC
38.4% more per $
DMRC
-47.2%
-85.6%
SURG
Faster 2-yr revenue CAGR
DMRC
DMRC
Annualised
DMRC
-5.3%
-28.2%
SURG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DMRC
DMRC
SURG
SURG
Revenue
$8.9M
$16.2M
Net Profit
$-4.2M
$-13.9M
Gross Margin
63.5%
-14.8%
Operating Margin
-48.2%
-79.1%
Net Margin
-47.2%
-85.6%
Revenue YoY
2.9%
68.7%
Net Profit YoY
51.4%
30.0%
EPS (diluted)
$-0.18
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DMRC
DMRC
SURG
SURG
Q4 25
$8.9M
$16.2M
Q3 25
$7.6M
$18.7M
Q2 25
$8.0M
$11.5M
Q1 25
$9.4M
$10.6M
Q4 24
$8.7M
$9.6M
Q3 24
$9.4M
$4.8M
Q2 24
$10.4M
$15.1M
Q1 24
$9.9M
$31.4M
Net Profit
DMRC
DMRC
SURG
SURG
Q4 25
$-4.2M
$-13.9M
Q3 25
$-8.2M
$-7.5M
Q2 25
$-8.2M
$-7.1M
Q1 25
$-11.7M
$-7.6M
Q4 24
$-8.6M
$-19.8M
Q3 24
$-10.8M
$-14.3M
Q2 24
$-9.3M
$-12.9M
Q1 24
$-10.3M
$1.2M
Gross Margin
DMRC
DMRC
SURG
SURG
Q4 25
63.5%
-14.8%
Q3 25
58.3%
-13.9%
Q2 25
58.8%
-23.0%
Q1 25
65.0%
-27.8%
Q4 24
60.8%
-117.0%
Q3 24
62.4%
-164.2%
Q2 24
66.1%
-22.8%
Q1 24
62.5%
26.0%
Operating Margin
DMRC
DMRC
SURG
SURG
Q4 25
-48.2%
-79.1%
Q3 25
-109.7%
-37.2%
Q2 25
-105.2%
-59.1%
Q1 25
-128.9%
-71.7%
Q4 24
-105.1%
-209.0%
Q3 24
-120.4%
-299.4%
Q2 24
-96.2%
-72.1%
Q1 24
-109.2%
5.6%
Net Margin
DMRC
DMRC
SURG
SURG
Q4 25
-47.2%
-85.6%
Q3 25
-106.9%
-40.1%
Q2 25
-102.6%
-61.5%
Q1 25
-125.2%
-72.2%
Q4 24
-99.9%
-206.5%
Q3 24
-113.9%
-299.3%
Q2 24
-89.3%
-85.3%
Q1 24
-104.0%
3.9%
EPS (diluted)
DMRC
DMRC
SURG
SURG
Q4 25
$-0.18
$-0.68
Q3 25
$-0.38
$-0.38
Q2 25
$-0.38
$-0.36
Q1 25
$-0.55
$-0.38
Q4 24
$-0.40
$-1.07
Q3 24
$-0.50
$-0.73
Q2 24
$-0.43
$-0.66
Q1 24
$-0.50
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DMRC
DMRC
SURG
SURG
Cash + ST InvestmentsLiquidity on hand
$12.9M
$1.7M
Total DebtLower is stronger
$13.3M
Stockholders' EquityBook value
$40.2M
$-15.3M
Total Assets
$53.0M
$8.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DMRC
DMRC
SURG
SURG
Q4 25
$12.9M
$1.7M
Q3 25
$12.6M
$2.5M
Q2 25
$16.1M
$4.4M
Q1 25
$21.6M
$5.4M
Q4 24
$28.7M
$11.8M
Q3 24
$33.7M
$23.7M
Q2 24
$41.5M
Q1 24
$48.9M
Total Debt
DMRC
DMRC
SURG
SURG
Q4 25
$13.3M
Q3 25
$12.0M
Q2 25
$9.6M
Q1 25
$3.6M
Q4 24
$4.0M
Q3 24
$4.4M
Q2 24
$4.8M
Q1 24
$5.2M
Stockholders' Equity
DMRC
DMRC
SURG
SURG
Q4 25
$40.2M
$-15.3M
Q3 25
$41.4M
$-6.4M
Q2 25
$46.5M
$116.1K
Q1 25
$50.0M
$7.8M
Q4 24
$61.4M
$15.3M
Q3 24
$70.2M
$33.2M
Q2 24
$77.2M
$46.2M
Q1 24
$84.5M
$56.0M
Total Assets
DMRC
DMRC
SURG
SURG
Q4 25
$53.0M
$8.5M
Q3 25
$55.4M
$14.5M
Q2 25
$60.7M
$15.2M
Q1 25
$66.5M
$15.7M
Q4 24
$75.8M
$24.0M
Q3 24
$85.0M
$41.5M
Q2 24
$93.4M
$56.4M
Q1 24
$99.7M
$69.6M
Debt / Equity
DMRC
DMRC
SURG
SURG
Q4 25
Q3 25
Q2 25
82.67×
Q1 25
0.46×
Q4 24
0.26×
Q3 24
0.13×
Q2 24
0.10×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DMRC
DMRC
SURG
SURG
Operating Cash FlowLast quarter
$991.0K
$-3.6M
Free Cash FlowOCF − Capex
$895.0K
FCF MarginFCF / Revenue
10.0%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DMRC
DMRC
SURG
SURG
Q4 25
$991.0K
$-3.6M
Q3 25
$-2.6M
$-4.6M
Q2 25
$-4.7M
$-6.1M
Q1 25
$-5.5M
$-7.0M
Q4 24
$-4.2M
$-7.9M
Q3 24
$-7.1M
$-13.3M
Q2 24
$-6.8M
$-4.1M
Q1 24
$-8.4M
$4.0M
Free Cash Flow
DMRC
DMRC
SURG
SURG
Q4 25
$895.0K
Q3 25
$-2.8M
Q2 25
$-4.9M
Q1 25
$-5.5M
Q4 24
$-4.2M
Q3 24
$-7.2M
Q2 24
$-6.9M
Q1 24
$-8.5M
FCF Margin
DMRC
DMRC
SURG
SURG
Q4 25
10.0%
Q3 25
-36.9%
Q2 25
-61.0%
Q1 25
-59.1%
Q4 24
-49.1%
Q3 24
-75.7%
Q2 24
-66.1%
Q1 24
-85.8%
Capex Intensity
DMRC
DMRC
SURG
SURG
Q4 25
1.1%
Q3 25
2.9%
Q2 25
2.5%
Q1 25
0.6%
Q4 24
0.2%
Q3 24
0.7%
Q2 24
0.3%
Q1 24
1.1%
Cash Conversion
DMRC
DMRC
SURG
SURG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
3.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DMRC
DMRC

Subscription$5.3M60%
The Government$3.6M41%

SURG
SURG

Segment breakdown not available.

Related Comparisons